JOHN C. REED - 17 Jul 2025 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Innovative Medicine, R&D
Signature
/s/ Laura H. McFalls, as attorney-in-fact for John C. Reed
Issuer symbol
JNJ
Transactions as of
17 Jul 2025
Net transactions value
-$3,129,830
Form type
4
Filing time
18 Jul 2025, 16:12:41 UTC
Previous filing
05 May 2025
Next filing
20 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
REED JOHN C EVP, Innovative Medicine, R&D ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK /s/ Laura H. McFalls, as attorney-in-fact for John C. Reed 18 Jul 2025 0001181561

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Sale $3,129,830 -19,137 -64% $163.55 10,658 17 Jul 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $163.52 to $163.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.